Device site stimulation for notification

• US 20070255339A1
• Filed: 04/28/2006
• Published: 11/01/2007
• Est. Priority Date: 04/28/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Torgerson, Nathan
• Granted Patent: US 7,774,056 B2
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/3605 Implantable neurostimulators for stimulating central or peripheral nerve system
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36185 Selection of the electrode configuration

Abstract

The disclosure is directed to techniques for delivering electrical stimulation for patient notification. An implantable medical device (IMD) may deliver patient notification stimulation via one or more device site electrodes, e.g., electrodes located proximate to an implant site for the IMD, configured as cathodes. Anodes for delivery the patient notification stimulation may be located in an electrode array that is provided by one or more leads and located distally from the implant site, e.g., an electrode array located at one or more target sites for delivery of stimulation therapy. In some embodiments, the IMD may inhibit the patient notification stimulation for a period in response to input from the patient, and then resume the stimulation at the end of the period. In this manner, the notification stimulation may be “snoozed” like an alarm clock. When the stimulation resumes, it may be different, e.g., more urgent, then prior to inhibition.

Claims

1. An implantable medical device comprising:

one or more device site electrodes located proximate to an implant location for the implantable medical device;

a lead-borne electrode array located distally from the implant location; and

a processor to control delivery of therapeutic stimulation via a first electrode configuration and patient notification stimulation via a second electrode configuration,

wherein the lead-borne electrode array includes each cathode for the first electrode configuration, and

wherein the one or more device site electrodes include each cathode for the second electrode configuration, and the lead-borne electrode array includes each anode for the second electrode configuration.

2. The implantable medical device of claim 1, further comprising a housing that contains the processor, wherein the one or more device site electrodes include the housing.

3. The implantable medical device of claim 1, further comprising a housing that contains the processor, wherein the one or more device site electrodes include a housing electrode located on the housing.

4. The implantable medical device of claim 1, wherein at least two electrodes within the lead-borne electrode array are anodes for the second electrode configuration.

5. The implantable medical device of claim 1, wherein at least four electrodes within the lead-borne electrode array are anodes for the second electrode configuration.

6. The implantable medical device of claim 1, wherein the lead-borne electrode array is implanted within the brain of the patient.

7. The implantable medical device of claim 1, wherein the implant location is beneath a scalp of the patient, and the device site electrodes are configured to contact the scalp.

8. The implantable medical device of claim 1, wherein the implantable medical device comprises a neurostimulator.

9. A method comprising:

delivering therapeutic stimulation from an implantable medical device to a patient via a first electrode configuration, wherein each cathode of the first electrode configuration is within a lead-borne electrode array located distally from an implant location for the implantable medical device; and

delivering patient notification stimulation from the implantable medical device to the patient via a second electrode configuration, wherein each cathode of the second electrode configuration is a device site electrode located proximate to the implant location, and each anode for the second electrode configuration is within the lead-borne electrode array.

10. The method of claim 9, wherein delivering the patient notification stimulation via the second electrode configuration comprises delivering the patient notification stimulation via a housing of the implantable medical device configured as a cathode.

11. The method of claim 9, wherein delivering the patient notification stimulation via the second electrode configuration comprises delivering the patient notification stimulation via a housing electrode located on a housing of the implantable medical device.

12. The method of claim 9, wherein delivering the patient notification stimulation via the second electrode configuration comprises delivering the patient notification stimulation via at least two electrodes within the lead-borne electrode array configured as anodes.

13. The method of claim 9, wherein delivering the patient notification stimulation via the second electrode configuration comprises delivering the patient notification stimulation via at least four electrodes within the lead-borne electrode array configured as anodes.

14. The method of claim 9, wherein the lead-borne electrode array is implanted within the brain of the patient.